2020's journey to extending healthy human Longevity.
The journey to Longevity has many stages, whether it's a clinical pipeline, gaining regulatory approval for a drug,...
Looking for anti-aging solutions in some unusual places.
2020 has seen Longevity.Technology covering a variety of news in the Longevity sector, from discoveries in the...
Speaking to the innovators behind some of Longevity’s most exciting companies.
Continuing our look back at some of the highlights of 2020, we thought we’d...
Collaboration set to establish new ventures for drug discovery and development and advance UCSF discoveries to patients.
Autobahn Labs has announced a strategic collaboration with...
Cerascreen expands from consumer biomarker testing into clinical trial recruitment and discovery of Longevity compounds.
Combining a wide range of consumer biomarker testing kits with...
Senescent cells promote NAD tissue decline during aging through CD38 enzymes which can now become a novel therapeutic target.
Nicotinamide adenine dinucleotide (NAD) is a...
Sigilon boosts its human cell therapeutics pipeline through IPO.
Sigilon Therapeutics, Inc, a biotech seeking to develop functional cures for chronic diseases through its Shielded...
Epigenetic aging clock DeepMAge has 3-year error margin and could be the most accurate DNA methylation clock to date.
Deep Longevity, the Hong-Kong based Longevity...
BioAge's Kristen Fortney explains how focusing on human data will see two age-targeting drugs head to the clinic next year.
Yesterday, the world again sat...
Silicon Valley's Rubedo Life Sciences closes $12m seed round for proprietary drug discovery platform that targets senolytics.
Following-on from BioAge's funding announcement another biotech start-up...
Company also appoints Chief Medical Officer as it prepares to enter the clinic with two Phase 2-ready therapeutic compounds that target aging pathways.
Longevity biotech...
64x Bio will use proprietary platform to spearhead cell and gene therapy manufacture.
Gene therapy can be a fantastic tool for targeting chronic age-related conditions;...
The anti-aging company looks to the clinic with Prime Movers Lab leading the round.
Massachusets-based Elevian announced this week that it had closed $15 million equity...
Keystone Bio seeks funding as it gears up for clinical trials of therapeutic targeting the “keystone pathogen” of chronic inflammaging.
Lurking in the mouths of...
AgeX commercialises its stem cell lines with continued support from stakeholder Juvenescence.
Biotech AgeX Therapeutics reported financial and operating results for the third quarter ended...
Dr Lynne Cox explains the importance of geroprotectors – especially during COVID-19.
This month The Lancet launches its own journal on Longevity, publishing clinically-focused Longevity and...
Rapamycin could be the PEARL in the Longevity oyster as new human trial seeks funding.
AgelessRx is a platform that sells drugs and supplements including...
Swedish study shows hydrogen peroxide can slow down the cell aging of yeast cells.
Known to most as a bleaching agent or antiseptic, hydrogen peroxide...
This Longevity category product approval will bode well for our sector and will make institutional investors take note.
Biogen's aducanumab, the first drug to actually...
